Kevin_1580

Kevin M. Lalande Managing Director

Prior to founding Santé Ventures, Kevin spent seven years with Austin Ventures, a prominent venture firm with $3.9 billion under management. Before joining Austin Ventures, he was a management consultant with McKinsey & Company. Previously, Kevin co-founded and sold three successful start-up companies: NetProfit, sold to a privately held advertising agency in 1996; Serus, sold to Netopia (Nasdaq: NTPA) in 1998; and TimeMarker, sold to PrimeHoldings (OTCBB: PRIM) in 2001. Kevin received an MBA with highest distinction (Baker Scholar) from the Harvard Business School and holds a BS in Electrical and Computer Engineering.

Why Venture Capital Doesn't Scale
News
February 21, 2019 Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies
Read More
December 27, 2018 Boston Scientific Exercises Option to Acquire Millipede, Inc. for $540M (Santé Ventures Leads Deal as Only Institutional Investor)
Read More